Approval · Notice of Compliance 2675 · 1998
HP-PAC: Notice of Compliance 2675
Issued July 30, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2675
- Date
- July 30, 1998
- Company
- Tap Pharmaceuticals, Inc.Lake Forest, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic H+, K+-atpase
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HP-PAC | 02238525 | Cancelled Post Market |
Medicinal ingredients
- AMOXICILLIN 500 MG per CAP
- CLARITHROMYCIN 500 MG per TAB
- LANSOPRAZOLE 30 MG per CAP